Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Infusion Systems | 6 | 2022 | 480 | 0.750 |
Why?
|
| Diabetes Mellitus, Type 1 | 10 | 2025 | 3922 | 0.650 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2017 | 46 | 0.640 |
Why?
|
| Virtual Reality | 1 | 2020 | 82 | 0.550 |
Why?
|
| Sulfonylurea Compounds | 1 | 2017 | 51 | 0.520 |
Why?
|
| Hypoglycemic Agents | 4 | 2025 | 1399 | 0.470 |
Why?
|
| Insulin | 3 | 2022 | 2512 | 0.390 |
Why?
|
| Hypoglycemia | 1 | 2017 | 479 | 0.370 |
Why?
|
| Diabetes Mellitus | 2 | 2017 | 1097 | 0.350 |
Why?
|
| Registries | 5 | 2017 | 2406 | 0.310 |
Why?
|
| Blood Glucose | 6 | 2025 | 2341 | 0.230 |
Why?
|
| Diabetic Nephropathies | 1 | 2025 | 322 | 0.170 |
Why?
|
| Pancreas, Artificial | 1 | 2022 | 97 | 0.160 |
Why?
|
| Depression | 2 | 2021 | 1546 | 0.160 |
Why?
|
| Attitude to Computers | 1 | 2020 | 28 | 0.150 |
Why?
|
| Overweight | 1 | 2025 | 614 | 0.150 |
Why?
|
| Cost of Illness | 1 | 2021 | 324 | 0.140 |
Why?
|
| Equipment and Supplies | 1 | 2018 | 36 | 0.140 |
Why?
|
| Directive Counseling | 1 | 2018 | 45 | 0.140 |
Why?
|
| Attitude | 1 | 2020 | 259 | 0.130 |
Why?
|
| Adolescent | 11 | 2023 | 22529 | 0.130 |
Why?
|
| Health Care Costs | 1 | 2021 | 425 | 0.130 |
Why?
|
| Personality | 1 | 2018 | 129 | 0.120 |
Why?
|
| Family | 1 | 2021 | 682 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 709 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2020 | 1111 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2020 | 1891 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 1419 | 0.100 |
Why?
|
| Parents | 2 | 2020 | 1403 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 881 | 0.090 |
Why?
|
| Biomarkers | 2 | 2025 | 4295 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 2187 | 0.090 |
Why?
|
| Sleep Wake Disorders | 1 | 2016 | 314 | 0.090 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2016 | 429 | 0.090 |
Why?
|
| Female | 13 | 2025 | 78844 | 0.080 |
Why?
|
| Obesity | 1 | 2025 | 3116 | 0.080 |
Why?
|
| Male | 12 | 2025 | 72842 | 0.080 |
Why?
|
| Child, Preschool | 7 | 2020 | 11853 | 0.080 |
Why?
|
| Blood Glucose Self-Monitoring | 3 | 2022 | 701 | 0.080 |
Why?
|
| Child | 9 | 2021 | 22707 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 1193 | 0.080 |
Why?
|
| Young Adult | 3 | 2021 | 14218 | 0.070 |
Why?
|
| Humans | 15 | 2025 | 145474 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 2378 | 0.070 |
Why?
|
| Adult | 8 | 2025 | 40777 | 0.060 |
Why?
|
| Neoplasms, Second Primary | 2 | 2000 | 102 | 0.060 |
Why?
|
| Mutation | 1 | 2016 | 4075 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 2588 | 0.050 |
Why?
|
| Middle Aged | 3 | 2025 | 36215 | 0.050 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 6066 | 0.050 |
Why?
|
| Risk | 4 | 2016 | 919 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 47 | 0.050 |
Why?
|
| Frustration | 1 | 2021 | 8 | 0.040 |
Why?
|
| Social Class | 1 | 2023 | 264 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2025 | 765 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2019 | 1001 | 0.040 |
Why?
|
| Patient Health Questionnaire | 1 | 2019 | 40 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2021 | 244 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2023 | 497 | 0.040 |
Why?
|
| Nuclear Family | 1 | 1998 | 50 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2025 | 1779 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2021 | 397 | 0.030 |
Why?
|
| Iceland | 4 | 2000 | 11 | 0.030 |
Why?
|
| Finland | 4 | 2000 | 78 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2018 | 500 | 0.030 |
Why?
|
| Legal Guardians | 1 | 2016 | 10 | 0.030 |
Why?
|
| Chicago | 1 | 2016 | 62 | 0.030 |
Why?
|
| Comprehension | 1 | 2018 | 186 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2025 | 2445 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2016 | 176 | 0.030 |
Why?
|
| Sex Factors | 2 | 2019 | 2105 | 0.030 |
Why?
|
| Siblings | 1 | 2016 | 196 | 0.030 |
Why?
|
| Emotions | 1 | 2021 | 574 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 302 | 0.030 |
Why?
|
| Age Factors | 2 | 2019 | 3342 | 0.030 |
Why?
|
| Hodgkin Disease | 1 | 1996 | 171 | 0.030 |
Why?
|
| Motivation | 1 | 2018 | 600 | 0.020 |
Why?
|
| Neoplasms | 3 | 2000 | 2906 | 0.020 |
Why?
|
| Cohort Studies | 4 | 2016 | 6013 | 0.020 |
Why?
|
| Decision Making | 1 | 2021 | 977 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 588 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2021 | 1674 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 777 | 0.020 |
Why?
|
| Mass Screening | 1 | 2021 | 1360 | 0.020 |
Why?
|
| Self Report | 1 | 2016 | 870 | 0.020 |
Why?
|
| Risk Factors | 3 | 2019 | 10885 | 0.020 |
Why?
|
| Quality of Life | 1 | 2022 | 3204 | 0.020 |
Why?
|
| Physicians | 1 | 2018 | 955 | 0.020 |
Why?
|
| Caregivers | 1 | 2018 | 1073 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2865 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7202 | 0.020 |
Why?
|
| Norway | 2 | 2000 | 41 | 0.020 |
Why?
|
| Denmark | 2 | 2000 | 51 | 0.020 |
Why?
|
| Scandinavian and Nordic Countries | 2 | 1998 | 14 | 0.020 |
Why?
|
| Sweden | 2 | 2000 | 115 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2025 | 17291 | 0.020 |
Why?
|
| Age of Onset | 2 | 2000 | 555 | 0.010 |
Why?
|
| Incidence | 3 | 1998 | 2923 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2000 | 330 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2000 | 204 | 0.010 |
Why?
|
| Retinal Neoplasms | 1 | 1998 | 37 | 0.010 |
Why?
|
| Retinoblastoma | 1 | 1998 | 42 | 0.010 |
Why?
|
| Infant | 3 | 1998 | 10077 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 1996 | 5423 | 0.010 |
Why?
|
| Survivors | 1 | 1998 | 523 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 1998 | 6447 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2000 | 3623 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2000 | 2214 | 0.000 |
Why?
|